Chlamydia trachomatis

Evaluation of Prevalence of Classical Fluoroquinolone Resistance Mechanisms in Chlamydia trachomatis Due to Mutations in the Topoisomerase Genes

Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):287-293

Until now, mutational resistance to fluoroquinolones (FQs) that represent a second-line treatment option for chlamydial infections after macrolides and tetrxacyclines has not been described in clinical isolates of C. trachomatis. However, a …

Generalization of Genital Chlamydia Infection

Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(4):351-360

Our study showed that chlamydiae were present in the blood from patients with genital and other chlamydial infections. Blood samples tested were positive for C. trachomatis in 92.3% of patients with confirmed chlamydial infection when culture and …

In vitro Antimicrobial Resistance of Chlamydia trachomatis: Methodological Aspects and Clinical Significance

Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(1):54-64

Susceptibility of 25 clinical isolates of Chlamydia trachomatis to the most commonly used antimicrobials for the treatment of chlamydial infections was studied. Of 25 isolates, 10 were determined as in vitro resistant to doxycycline, 10 – to …